MX2015001019A - Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos. - Google Patents

Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos.

Info

Publication number
MX2015001019A
MX2015001019A MX2015001019A MX2015001019A MX2015001019A MX 2015001019 A MX2015001019 A MX 2015001019A MX 2015001019 A MX2015001019 A MX 2015001019A MX 2015001019 A MX2015001019 A MX 2015001019A MX 2015001019 A MX2015001019 A MX 2015001019A
Authority
MX
Mexico
Prior art keywords
treatment
sores
wounds
amino acids
hypochlorite
Prior art date
Application number
MX2015001019A
Other languages
English (en)
Other versions
MX360207B (es
Inventor
Ulrica Almhöjd
Karin Bergqvist
Original Assignee
Rls Global Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rls Global Ab filed Critical Rls Global Ab
Publication of MX2015001019A publication Critical patent/MX2015001019A/es
Publication of MX360207B publication Critical patent/MX360207B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Un kit de partes para usarse en prevención y/o tratamiento de llagas, heridas, úlceras o similares o una fístula u otitis. El kit de partes comprende un primer componente acuoso que comprende uno o más aminoácidos, y un segundo componente acuoso que comprende un compuesto de halógeno activo, en donde el pH del primer componente y/o el segundo componente es aproximadamente 9 a 11.5. Se proporciona también una preparación de tratamiento preparada de los componentes y usos de la misma en la prevención y/o tratamiento de llagas, heridas, úlceras, o similares, o una fístula u otitis.
MX2015001019A 2012-07-24 2013-07-15 Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos. MX360207B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1250891A SE536581C2 (sv) 2012-07-24 2012-07-24 Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
PCT/EP2013/064919 WO2014016157A1 (en) 2012-07-24 2013-07-15 Preparation for treatment of wounds and sores comprising hypochlorite and amino acids

Publications (2)

Publication Number Publication Date
MX2015001019A true MX2015001019A (es) 2015-04-08
MX360207B MX360207B (es) 2018-10-24

Family

ID=48783266

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015001019A MX360207B (es) 2012-07-24 2013-07-15 Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos.

Country Status (9)

Country Link
US (1) US9999605B2 (es)
EP (2) EP3299022A1 (es)
JP (1) JP6169693B2 (es)
CN (1) CN104619330B (es)
CA (1) CA2879362C (es)
ES (1) ES2657598T3 (es)
MX (1) MX360207B (es)
SE (1) SE536581C2 (es)
WO (1) WO2014016157A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav
AU2014343506C1 (en) 2013-10-29 2023-06-01 Hypo-Stream Limited Anti-inflammatory solution comprising sodium hypochlorite
GB2519774A (en) * 2013-10-29 2015-05-06 Hypo Stream Ltd Anti-inflammatory solution
RU2684415C1 (ru) * 2018-04-18 2019-04-09 Федеральное государственное бюджетное образовательное учреждение высшего образования Кубанский государственный медицинский университет Министерства здравоохранения Российской Федерации, ФГБОУ ВО КубГМУ МЗ РФ Способ лечения гнойных ран
CN114555073A (zh) * 2019-09-19 2022-05-27 Rls全球公司 用于去除和/或预防与表皮葡萄球菌相关的感染的制剂
RU2741954C1 (ru) * 2020-07-20 2021-02-01 Государственное бюджетное учреждение здравоохранения "Научно-исследовательский институт - краевая клиническая больница N 1 имени профессора С.В. Очаповского" Министерства здравоохранения Краснодарского края (ГБУЗ "НИИ-ККБ N 1 им. проф. Очаповского" Минздрава Краснодарского края) Способ лечения локальных ран головы с остеонекрозом костей свода черепа

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1418193A (en) 1973-03-14 1975-12-17 Wilkinson Sword Ltd Dispenser for hypochlorite gels
US3950536A (en) 1974-02-01 1976-04-13 Sol Joseph Barer N,N-Dichloro substituted aminocarboxylic acids as bactericides and fungicides
JPH0233013B2 (ja) 1980-03-21 1990-07-25 Masatoshi Fumiiri Sokonchiryozai
GB8324487D0 (en) 1983-09-13 1983-10-12 Geistlich Soehne Ag Topically administrable pharmaceutical compositions
SE507437C2 (sv) 1996-11-14 1998-06-08 Medi Team Dentalutveckling I G Preparat för användning vid kemisk-mekanisk behandling av kariesangrepp och förfarande för framställning av preparatet
JPH10175857A (ja) 1996-12-19 1998-06-30 Sekisui Chem Co Ltd 創傷治療剤
US6350438B1 (en) 1998-02-27 2002-02-26 The Procter & Gamble Company Oral care compositions comprising chlorite and methods
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
ATE220918T1 (de) 1998-02-27 2002-08-15 Biora Bioex Ab Matrixprotein enthaltende zusammensetzungen zur wundheilung
FR2819723B1 (fr) 2001-01-23 2006-11-17 Arnaud Mainnemare Composition halogene, son procede de preparation et ses utilisations
US20030194445A1 (en) * 2001-11-12 2003-10-16 Kuhner Carla H. Compositions and methods of use of peptides in combination with biocides and/or germicides
US8388990B2 (en) 2002-10-07 2013-03-05 Ecolab Usa Inc. Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto
ES2444845T3 (es) 2003-08-18 2014-02-27 Novabay Pharmaceuticals, Inc. Aminoácidos N,N-dihalogenados y derivados
US7423064B2 (en) * 2004-09-24 2008-09-09 Olatec Industries, Llc Composition for treating bacterial, viral, fungal diseases, inflammation and pain
TWI386201B (zh) 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
US20070032754A1 (en) * 2005-08-02 2007-02-08 Walsh Richard F Method and apparatus for treating a wound
TW200843787A (en) 2006-12-29 2008-11-16 Novabay Pharmaceuticals Inc N-halogenated amino compounds and derivatives; compositions and methods of using them
KR20080082742A (ko) 2007-03-09 2008-09-12 이향락 충치 제거제
UY31058A1 (es) 2007-05-01 2008-10-31 Alcon Res Ltd Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios
US7879798B1 (en) 2007-08-24 2011-02-01 Regenicel, Inc. Composition for indolent wound healing and methods of use therefor
UY31055A1 (es) 2008-02-01 2008-10-31 Alcon Res Ltd Sales antimicrobianas de aminoacido n-halogenado
WO2010017405A1 (en) 2008-08-06 2010-02-11 Adam Heller Methods and compositions for the treatment of pain
US20100204181A1 (en) 2009-02-06 2010-08-12 Alcon Research, Ltd. N-halogenated amino acid formulations comprising phosphine or amine oxides
CN102438983A (zh) 2009-03-18 2012-05-02 欧拉泰克工业有限责任公司 用于治疗炎症和疼痛的化合物
US20110020474A1 (en) 2009-07-27 2011-01-27 Novabay Pharmaceuticals, Inc. Methods of Treating Infections of the Nail or Skin Using Hypohalite
WO2011017030A2 (en) 2009-08-06 2011-02-10 Neuraltus Pharmaceuticals, Inc. Treatment of macrophage-related disorders
US8486155B2 (en) * 2010-05-13 2013-07-16 Ethicon Endo-Surgery, Inc. Fistula repair plug having multiple layers
EP2510944A1 (en) 2011-04-15 2012-10-17 National University of Ireland, Galway Treatment of bacterial infections
BR112014008255B1 (pt) * 2011-10-08 2020-12-15 Next Science IP Holdings Pty Ltd Composições antimicrobianas e métodos empregando as mesmas
SE536581C2 (sv) 2012-07-24 2014-03-11 Rls Global Ab Ett kit för behandling av sår eller liknande och ett preparat och metoder därav

Also Published As

Publication number Publication date
CN104619330A (zh) 2015-05-13
CA2879362C (en) 2020-09-22
EP3299022A1 (en) 2018-03-28
EP2877188A1 (en) 2015-06-03
ES2657598T3 (es) 2018-03-06
JP2015522632A (ja) 2015-08-06
US20150174091A1 (en) 2015-06-25
SE1250891A1 (sv) 2014-01-25
SE536581C2 (sv) 2014-03-11
EP2877188B1 (en) 2017-10-25
CN104619330B (zh) 2018-01-19
US9999605B2 (en) 2018-06-19
WO2014016157A1 (en) 2014-01-30
CA2879362A1 (en) 2014-01-30
JP6169693B2 (ja) 2017-07-26
MX360207B (es) 2018-10-24

Similar Documents

Publication Publication Date Title
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
MX2015001019A (es) Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos.
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
CA2897273C (en) Benzylamine derivatives
MX340533B (es) Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
MX348974B (es) Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
GEP201706780B (en) Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MX2013003634A (es) Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales.
WO2014188178A9 (en) Polymyxin derivatives and their use in combination therapy together with different antibiotics
EA201270566A1 (ru) Противомикробные соединения и способы их получения и применения
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
WO2011140310A3 (en) Povidone-iodine topical composition
WO2019040106A3 (en) COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES
AU2011208681A8 (en) Aqueous solution comprising 3 - quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
UA115357C2 (uk) Похідні піридин-4-ілу
WO2013106689A8 (en) Hcv ns3 protease inhibitors
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MX2012008890A (es) Composicion de combinacion, que comrpende como ingrediente activo l-carnitina o propionil l-carnitina, para la prevencion o tratamiento de insuficiencia venosa cronica.
PH12019501469A1 (en) Compositions and methods for treating biofilms
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
WO2015084883A3 (en) Compositions and methods for treating osteoarthritis
MX2013002208A (es) Derivados de sulfonilpiperazina que interactuan con la proteina reguladora de glucocinasa para el tratamiento de diabetes.
WO2013162933A3 (en) Active halogen antimicrobial composition and method of use
MX2019006768A (es) Peptidos antimicrobianos.
MX357888B (es) Sales basicas de adicion de nitroxolina y usos de las mismas.

Legal Events

Date Code Title Description
FG Grant or registration